Celldex Therapeutics
Michael Yellin possesses extensive experience in the field of clinical science, currently serving as Vice President of Clinical Science at Celldex Therapeutics since January 2010. Prior to this role, Michael held the position of Senior Director at Medarex from October 2001 to January 2010. This extensive background highlights a robust career dedicated to advancing clinical research and development.
This person is not in any offices